AI assistant
Sending…
GILEAD SCIENCES, INC. — Director's Dealing 2016
Aug 2, 2016
29828_dirs_2016-08-02_8e0392f4-1506-4cff-9eb8-2b0c8b4b3d44.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2016-07-31
Reporting Person: Carter Paul Rutherford (EVP Commercial Ops)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-07-31 | Common Stock | M | 2500 | — | Acquired | 63622 | Direct |
| 2016-07-31 | Common Stock | F | 1317 | $79.47 | Disposed | 62305 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-07-31 | Restricted Stock Unit | $ | M | 2500 | Disposed | Common Stock (2500) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2: The restricted stock units vest 25% annually over a four year period after the date of grant.
More from GILEAD SCIENCES, INC.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 30